These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10403438)

  • 1. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats.
    Modric S; Webb AI; Davidson M
    Lab Anim Sci; 1999 Jun; 49(3):248-53. PubMed ID: 10403438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks.
    Jordan FT; Horrocks BK
    Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tilmicosin in equine tissues and plasma.
    Clark C; Dowling PM; Ross S; Woodbury M; Boison JO
    J Vet Pharmacol Ther; 2008 Feb; 31(1):66-70. PubMed ID: 18177321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tilmicosin for treatment of pasteurellosis in rabbits.
    McKay SG; Morck DW; Merrill JK; Olson ME; Chan SC; Pap KM
    Am J Vet Res; 1996 Aug; 57(8):1180-4. PubMed ID: 8836371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tilmicosin in the control of experimental Mycoplasma gallisepticum infection in chickens.
    Kempf I; Reeve-Johnson L; Gesbert F; Guittet M
    Avian Dis; 1997; 41(4):802-7. PubMed ID: 9454912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells.
    Scorneaux B; Shryock TR
    J Dairy Sci; 1999 Jun; 82(6):1202-12. PubMed ID: 10386306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of an aqueous preparation of tilmicosin with tylosin in the treatment of Mycoplasma gallisepticum infection of turkey poults.
    Jordan FT; Forrester CA; Hodge A; Reeve-Johnson LG
    Avian Dis; 1999; 43(3):521-5. PubMed ID: 10494422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoplasma pulmonis genital disease: effect of rat strain on pregnancy outcome.
    Reyes L; Steiner DA; Hutchison J; Crenshaw B; Brown MB
    Comp Med; 2000 Dec; 50(6):622-7. PubMed ID: 11200568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum.
    Clark C; Woodbury M; Dowling P; Ross S; Boison JO
    J Vet Pharmacol Ther; 2004 Oct; 27(5):385-7. PubMed ID: 15500580
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs.
    Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG
    Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bentonite incorporated in a feed ration with tilmicosin in the prevention of induced Mycoplasma gallisepticum airsacculitis in broiler chickens.
    Shryock TR; Klink PR; Readnour RS; Tonkinson LV
    Avian Dis; 1994; 38(3):501-5. PubMed ID: 7832702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residue depletion of tilmicosin in cattle after subcutaneous administration.
    Jiang H; Ding S; Li J; An D; Li C; Shen J
    J Agric Food Chem; 2006 Jul; 54(14):5208-13. PubMed ID: 16819937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the pharmacokinetics of tilmicosin in plasma and lung tissue in healthy chickens and chickens experimentally infected with Mycoplasma gallisepticum.
    Zhang N; Liu Z; Wei Y; Zhang C; Mao C; Cai Q; Shen X; Ding H
    J Vet Pharmacol Ther; 2020 Jul; 43(4):347-354. PubMed ID: 32133660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration.
    Lombardi KR; Portillo T; Hassfurther R; Hunter RP
    J Vet Pharmacol Ther; 2011 Dec; 34(6):583-7. PubMed ID: 21323676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tissue depletion of tilmicosin in turkeys.
    Fricke JA; Clark CR; Boison JO; Chirino-Trejo M; Inglis TE; Dowling PM
    J Vet Pharmacol Ther; 2008 Dec; 31(6):591-4. PubMed ID: 19000285
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of calf pneumonia with tilmicosin.
    Fodor L; Varga J; Gallowitsch F; Horváth-Papp I; Miklós G; Lajcsák A; Harmath A
    Acta Vet Hung; 1993; 41(1-2):41-9. PubMed ID: 8116500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of tilmicosin in lactating ewes.
    Atef M; Abo el-Sooud K; Nahed E; Tawfik M
    Dtsch Tierarztl Wochenschr; 1999 Jul; 106(7):291-4. PubMed ID: 10481373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle.
    Vogel GJ; Laudert SB; Zimmermann A; Guthrie CA; Mechor GD; Moore GM
    J Am Vet Med Assoc; 1998 Jun; 212(12):1919-24. PubMed ID: 9638194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
    Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
    J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible protective effect of L-carnitine on tilmicosin-induced cardiotoxicity in mice.
    Kart A; Yapar K; Karapehlivan M; Citil M
    J Vet Med A Physiol Pathol Clin Med; 2007 Apr; 54(3):144-6. PubMed ID: 17381679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.